Wells Fargo & Company Amgen Inc Call Options Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $1.61 Million - $1.95 Million	6,000 Added 1000.0%	6,600 $1.88 Million
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $1.18 Million - $1.39 Million	-5,500 Reduced 90.16%	600 $133,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $451,580 - $550,400	2,000 Added 48.78%	6,100 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $939,023 - $1.19 Million	4,100 New	4,100 $1.08 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $1.66 Million - $1.94 Million	7,500 New	7,500 $1.87 Million

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.